BioTuesdays

Tag - Brian Weinstein

Sera Prognostics
Markets

WB starts Sera Prognostics at OP

William Blair launched coverage of Sera Prognostics (NASDAQ:SERA), a pregnancy diagnostics company, with an “outperform” rating. The stock closed at $12.85 on Aug. 6. Analyst Brian Weinstein writes that the current rate...

August 9, 2021
Lucira-Health-Logo
Markets

WB cuts Lucira Heath to market perform

William Blair downgraded Lucira Health (NASDAQ:LHDX) to “market perform,” citing changes to the testing market that have played out over the last couple of months coupled with lack of demand for the company’s at-home...

May 4, 2021
Lucira-Health-Logo
Markets

WB starts Lucira Health at OP

William Blair initiated coverage of Lucira Health (NASDAQ:LHDX) with an “outperform” rating, based on “our outlook for a series of positive catalysts on commercialization and manufacturing as well as what we believe is...

March 2, 2021
Aspira-Women's-Health-Logo
Markets

William Blair starts Aspira Women’s Health at OP

William Blair launched coverage of Aspira Women’s Health (NASDAQ:AWH) with an “outperform” rating. The stock closed at $3.63 on Oct. 29. The company’s current product line, the OVA family, is used for presurgical pelvic...

October 30, 2020
DermTech-Logo
Markets

William Blair starts DermTech at OP

William Blair initiated coverage of DermTech (NASDAQ:DMTK) with an “outperform” rating. The stock closed at $11.75 on Oct. 29. Analyst Brian Weinstein writes that DermTech is focused on driving adoption of its non...

October 30, 2020